搜期刊
刊名

文献信息

  • 任意字段
  • 主题词
  • 篇关摘
  • 篇名
  • 关键词
  • 摘要
  • 作者
  • 第一作者
  • 作者单位
  • 刊名
  • 中图分类号
  • 学科分类号
  • DOI
  • 基金

Anti - Cancer Drugs 中科院4区 JCR:Q3 SCIE CA PubMed JST
发文量 4,897
被引量 118,736
影响因子(2025版) 2.287

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

  • 主办单位: LIPPINCOTT WILLIAMS & WILKINS
  • 出版地区: PHILADELPHIA
  • 出版周期: 月刊
  • 别名: ANTI-CANCER DRUG;Anti-Cancer Drugs;Anti-Cancer Drugs;ANTI-CANCER DRUGS;抗肿瘤药物;Anticancer Drugs
  • 国际标准连续出版物号/电子版 ISSN 0959-4973 / EISSN 1473-5741
  • 创刊时间: 1990年
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
新发布(2025版)
分析评价
  • 1
  • 2
  • 3
  • 4